1. Home
  2. AKR vs KNSA Comparison

AKR vs KNSA Comparison

Compare AKR & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKR
  • KNSA
  • Stock Information
  • Founded
  • AKR 1993
  • KNSA 2015
  • Country
  • AKR United States
  • KNSA United Kingdom
  • Employees
  • AKR N/A
  • KNSA N/A
  • Industry
  • AKR Real Estate Investment Trusts
  • KNSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AKR Real Estate
  • KNSA Health Care
  • Exchange
  • AKR Nasdaq
  • KNSA Nasdaq
  • Market Cap
  • AKR 2.5B
  • KNSA 1.9B
  • IPO Year
  • AKR 1993
  • KNSA 2018
  • Fundamental
  • Price
  • AKR $18.63
  • KNSA $30.06
  • Analyst Decision
  • AKR Strong Buy
  • KNSA Strong Buy
  • Analyst Count
  • AKR 2
  • KNSA 6
  • Target Price
  • AKR $25.00
  • KNSA $40.83
  • AVG Volume (30 Days)
  • AKR 1.4M
  • KNSA 641.3K
  • Earning Date
  • AKR 07-29-2025
  • KNSA 07-29-2025
  • Dividend Yield
  • AKR 4.26%
  • KNSA N/A
  • EPS Growth
  • AKR 1674.19
  • KNSA N/A
  • EPS
  • AKR 0.16
  • KNSA 0.07
  • Revenue
  • AKR $402,216,000.00
  • KNSA $529,332,000.00
  • Revenue This Year
  • AKR N/A
  • KNSA $37.21
  • Revenue Next Year
  • AKR $11.00
  • KNSA $6.10
  • P/E Ratio
  • AKR $118.60
  • KNSA $453.69
  • Revenue Growth
  • AKR 16.79
  • KNSA 56.18
  • 52 Week Low
  • AKR $16.98
  • KNSA $17.82
  • 52 Week High
  • AKR $26.29
  • KNSA $31.92
  • Technical
  • Relative Strength Index (RSI)
  • AKR 47.46
  • KNSA 60.51
  • Support Level
  • AKR $18.60
  • KNSA $26.27
  • Resistance Level
  • AKR $19.16
  • KNSA $31.92
  • Average True Range (ATR)
  • AKR 0.43
  • KNSA 1.03
  • MACD
  • AKR 0.05
  • KNSA 0.13
  • Stochastic Oscillator
  • AKR 51.36
  • KNSA 67.08

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: Core Portfolio segment consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds primarily retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Share on Social Networks: